Amplifold is a seed startup based in Germany. 1 investor tracked.
Based in Germany, Amplifold is a startup. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Amplifold is an LMU Munich spin-off that develops an ultrasensitive signal amplification platform for lateral flow immunoassays using DNA-origami nanostructures to increase sensitivity of rapid diagnostic tests. The technology acts as programmable adapters to enhance detection limits (reported up to ~100-fold) while keeping tests low-cost and robust.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.